logo
episode-header-image
Jul 2022
29m 14s

FT Weekend: A new weight-loss drug works...

Financial Times
About this episode
tail spinning
Up next
Today
Andy Burnham’s first Labour conference as prime minister
UK Prime Minister Andy Burnham returns to the Labour conference to sell his vision, EU countries are considering a Nato-style joint response to Russia’s hybrid war, and foreign investors have been buying up Panama’s debt despite social unrest and threats from US President Donald ... Show More
10m 49s
Sep 25
Bond rout pushes US mortgage rates past 7%
Xi Jinping said the US and China should avoid being drawn into a “conflict” in remarks at the White House, and Brussels has warned Britain needs to raise tariffs on Chinese cars if it wants to avoid barriers that would hit crucial exports. Plus, dozens of foreign officials walked ... Show More
12m 38s
Sep 24
US Treasury yields soar
US Treasury yields soared on Wednesday, Iran’s President Masoud Pezeshkian said Tehran was prepared to negotiate with the US, and the FT’s Sam Fleming explains why the UK budget is in a tight spot. Plus, billions of dollars of Rosneft’s foreign earnings were funnelled through a K ... Show More
11m 34s
Recommended Episodes
Jul 2023
One Thing: Weight Loss Drugs: Trend or Treatment?
A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ... Show More
17m 14s
Dec 2024
A checkup on weight-loss drugs
What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ... Show More
20m 17s
Apr 2023
Those New Obesity Drugs Really Work–If You Can Afford Them
Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ... Show More
25m 18s
May 2024
Ozempic: Magic Pill or Devil’s Bargain?
Ozempic has fast become the buzzword for dramatic weight loss, and considering the results users have been reporting, it’s easy to see why. To discuss the supposed miracle drug, Piers Morgan has assembled an all-star panel of doctors and patients, including; Journalist and author ... Show More
45m 22s
Jan 2024
Is Ozempic Really A Miracle Drug?
New drugs like Wegovy, Ozempic and Mounjaro are billed as a revolutionary new approach for losing weight. But are these actually miracle drugs? Dr. Sanjay Gupta turns to Yale School of Medicine assistant professor Dr. Jorge Moreno to explain the science behind these medications – ... Show More
30m 13s
Dec 2024
068 | The weight is over: How GLP-1 treatments are reshaping pharma and beyond
Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ... Show More
11m 16s
Dec 2023
The Weight-Loss Drug Revolution, Part 1: Why These Drugs Work So Well
Today’s podcast is about the weight-loss drug revolution—which I believe might be one of the most important stories in the world right now. Despite all the attention weight-loss drugs are receiving, it’s possible that they might soon affect the world even more than we realize as ... Show More
50m 34s